Media Release by MTPConnect
A new voucher scheme from the MTPConnect WA Life Sciences Innovation Hub will see a major boost for medical products manufacturing in Western Australia.
Under the scheme, five WA-based companies have been awarded a total of $450,000 to accelerate innovation projects requiring advanced manufacturing capabilities.
Matched with cash co-contributions of $600,000, the initiative is injecting more than $1 million into
WA’s medical technology, biotechnology and pharmaceutical sector to drive job creation and economic growth.
Awardees include:
- OncoRes Medical Pty Ltd – clinical feasibility of a diagnostic imaging device for cancer surgery
- Proteomics International Pty Ltd – manufacturing next generation in vitro device to predict diabetic kidney disease
- SynGenis Pty Ltd – establishing certified oligonucleotide (DNA and RNA) manufacturing capabilities in WA
- VeinTech Pty Ltd – VeinWave: improving first pass cannulation success
- VitalTrace Pty Ltd – developing Perth into Australia’s flagship precision healthcare biosensor development and manufacturing hub
MTPConnect Managing Director and CEO, Dr Dan Grant, congratulated the five successful companies.
“Manufacturing medical products is a national priority so we’re supporting these promising projects to develop their medical devices and diagnostics,” Dr Grant said.
“Each project is aiming to improve the health and wellbeing of Australians and if we can help them along the commercialisation pathway through our voucher initiative, these companies will also continue contributing to the state’s burgeoning innovation ecosystem.”
The voucher initiative, announced by Health and State Development, Jobs and Trade Minister Roger Cook MLA, is being made available through the MTPConnect WA Life Sciences Innovation Hub, which is co-funded by MTPConnect, the University of Western Australia and the WA Government through the New Industries Fund.
All projects are due to be completed by 30 May 2022.
